Apogee Therapeutics, Inc Common Stock
Price & Volume
Stats
See moreOpen | $78.57 |
Previous Close | $77.48 |
Day Range | $77.73-$79.65 |
52W Range | $26.20-$80.99 |
Market Cap | $5.3B |
Shares Short | 8M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$4.38 |
News
See moreYahoo Finance • 2 months ago
Apogee Therapeutics reports Q3 results
Yahoo Finance • 2 months ago
Apogee Therapeutics Provides Pipeline Progress and Reports Third Quarter 2025 Financial Results
Yahoo Finance • 2 months ago
Apogee Therapeutics Announces Positive Interim Phase 1 Results from Healthy Volunteer Trial of APG333, its Novel Half-Life Extended TSLP Antibody
Yahoo Finance • 2 months ago
Apogee Therapeutics to Participate in Upcoming Conferences
About
CEO | Dr. Michael Thomas Henderson M.D. |
Address | Building 17, Waltham, MA, United States, 02453 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 196 |
